NASDAQ Composite opens in less than five hours and Arcturus Therapeutics‘s pre-market value is already 8.04% down.
The last session, NASDAQ Composite ended with Arcturus Therapeutics sliding 5.81% to $27.23. NASDAQ Composite dropped 0.09% to $13,389.43, after two consecutive sessions in a row of losses, on what was a somewhat rough trend exchanging session.
Arcturus Therapeutics’s last close was $28.91, 376.35% below its 52-week high of $129.71.
Arcturus Therapeutics’s Revenue
Year-on-year quarterly revenue growth declined by 24.6%, now sitting on 9.54M for the twelve trailing months.
Arcturus Therapeutics’s last day, last week, and last month’s current volatility was 10.00%, 6.74%, and 3.98%, respectively.
Arcturus Therapeutics’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 7.51% (day), 7.98% (last week), and 6.93% (last month), respectively.
More news about Arcturus Therapeutics.